Companion Diagnostics for Oncology market to Surge at 13.02% CAGR, which is anticipated to reach USD 8.45 billion by 2030.
Region-wise, the market in North America which held the largest market share in the year 2019, emerged as a key market for Companion Diagnostics for Oncology market.
Read More